Dr. Carl June is seeking to take the cancer-fighting cell therapy he developed more than a dozen years ago at the University of Pennsylvania to the next level. Penn ...
This year will be regarded as an inflection point for the treatment of glioblastoma, a rare and aggressive form of brain cancer that carries a median survival time of around 15 to 18 months, said Carl ...
Genesis Outpatient Pediatric Therapy Center earned a percentage of proceeds from Xpress Tunnel Wash during a fundraiser in late 2010. The center earned a portion of sales from families of children and ...
Perelman School of Medicine professor Carl June at the flash mob celebration for the FDA approval of the CAR T cell therapy he developed, in August 2017 (Photo courtesy of Penn Medicine). Perelman ...
Researcher Carl June led the Penn Medicine team that first used CAR-T cell therapy — a Penn-pioneered cancer treatment — to treat adult leukemia patients in 2010. In 2012, Emily Whitehead was the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results